Tanvex BioPharma, Inc. announced the appointment of Wen Chung Yeh as Chief financial officer with effect on November 13, 2023. Date of occurrence of the change: November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.55 TWD | +1.25% | +13.36% | -31.57% |
06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
1st Jan change | Capi. | |
---|---|---|
-31.57% | 221M | |
+16.54% | 122B | |
+20.11% | 115B | |
+21.22% | 26.64B | |
-23.50% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.65% | 15.49B | |
+61.93% | 14.83B | |
+2.69% | 13.67B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer